Source:http://linkedlifedata.com/resource/pubmed/id/17729112
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2007-8-30
|
pubmed:abstractText |
To investigate changes in oxidant stress during and following acute asthma exacerbations, this study measured 2,3-dinor-5,6-dihydro-15-F(2t)-IsoP (F(2)-IsoP-M), the major urinary metabolite of 15-F(2t)-IsoP, in eight asthmatic adults, during and following an asthma hospitalization. F(2)-IsoP-M concentrations at admission and follow-up were significantly higher than discharge (admission median: 4.12 ng/Cr mg, range 1.89-7.8; follow-up: 2.47 ng/Cr mg (1.56-6.86); discharge: 1.42 ng/Cr mg (0.7-4.44); both p<0.01), but not significantly different between admission and follow-up. F(2)-IsoP-M concentrations at follow-up were higher than a control group with stable asthma (0.68 ng/Cr mg (0.31-1.5), p=0.0008). In conclusion, asthma exacerbations requiring hospitalization are associated with 6-fold higher urinary F(2)-IsoP-M concentrations compared to stable asthmatics. F(2)-IsoP-M concentrations decreased significantly during hospitalization, but significant elevations 3 months following hospitalization suggest ongoing oxidative stress despite clinical improvement. Urinary F(2)-IsoP-M may be a clinically useful, simple non-invasive systemic measure of oxidative stress in asthmatics, providing information not captured by spirometry or symptoms.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/K08 AI001582,
http://linkedlifedata.com/resource/pubmed/grant/M01 RR00095,
http://linkedlifedata.com/resource/pubmed/grant/P50 GM15431,
http://linkedlifedata.com/resource/pubmed/grant/R01 AI50884,
http://linkedlifedata.com/resource/pubmed/grant/R37 GM42056
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2,3-dinor-5,6-dihydro-15-F-isoprosta...,
http://linkedlifedata.com/resource/pubmed/chemical/8-epi-prostaglandin F2alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprost
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1071-5762
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
956-62
|
pubmed:meshHeading |
pubmed-meshheading:17729112-Adult,
pubmed-meshheading:17729112-Asthma,
pubmed-meshheading:17729112-Biological Markers,
pubmed-meshheading:17729112-Case-Control Studies,
pubmed-meshheading:17729112-Dinoprost,
pubmed-meshheading:17729112-Female,
pubmed-meshheading:17729112-Humans,
pubmed-meshheading:17729112-Male,
pubmed-meshheading:17729112-Middle Aged,
pubmed-meshheading:17729112-Oxidative Stress
|
pubmed:year |
2007
|
pubmed:articleTitle |
Changes in urinary dinor dihydro F(2)-isoprostane metabolite concentrations, a marker of oxidative stress, during and following asthma exacerbations.
|
pubmed:affiliation |
Department of Medicine and the Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|